{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T09:12:35Z","timestamp":1789549955555,"version":"build-2803163510"},"reference-count":39,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.3201\/eid2111.150404","type":"journal-article","created":{"date-parts":[[2015,10,19]],"date-time":"2015-10-19T10:56:11Z","timestamp":1445252171000},"source":"Crossref","is-referenced-by-count":78,"title":["Uncommon<i>Candida<\/i>Species Fungemia among Cancer Patients, Houston, Texas, USA"],"prefix":"10.3201","volume":"21","author":[{"given":"Dong Sik","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Farmakiotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J.","family":"Tarrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios P.","family":"Kontoyiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2111.150404-201510190655-R1","doi-asserted-by":"publisher","first-page":"4745","DOI":"10.1002\/cncr.24507","article-title":"Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001\u20132007): stable incidence but changing epidemiology of a still frequently lethal infection.","volume":"115","author":"Sipsas","year":"2009","journal-title":"Cancer"},{"key":"key-10.3201\/eid2111.150404-201510190655-R2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10408410903241444","article-title":"Epidemiology of invasive mycoses in North America.","volume":"36","author":"Pfaller","year":"2010","journal-title":"Crit Rev Microbiol"},{"key":"key-10.3201\/eid2111.150404-201510190655-R3","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1086\/380637","article-title":"Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991\u20132000.","volume":"38","author":"Marchetti","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2111.150404-201510190655-R4","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1093\/cid\/cis697","article-title":"Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008\u20132011.","volume":"55","author":"Cleveland","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2111.150404-201510190655-R5","doi-asserted-by":"publisher","first-page":"e101510","DOI":"10.1371\/journal.pone.0101510","article-title":"Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the prospective antifungal therapy (PATH) Registry 2004\u20132008.","volume":"9","author":"Pfaller","year":"2014","journal-title":"PLoS ONE"},{"key":"key-10.3201\/eid2111.150404-201510190655-R6","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1086\/315193","article-title":"Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole.","volume":"181","author":"Marr","year":"2000","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2111.150404-201510190655-R7","doi-asserted-by":"publisher","first-page":"5358","DOI":"10.1128\/AAC.00690-11","article-title":"Prior caspofungin exposure in patients with hematological malignancies is a risk factor for subsequent fungemia due to decreased susceptibility in Candida spp.: a case-control study in Paris, France.","volume":"55","author":"Blanchard","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2111.150404-201510190655-R8","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/00005792-199807000-00003","article-title":"The effect of prophylactic fluconazole on the clinical spectrum of fungal diseases in bone marrow transplantation recipients with special attention to hepatic candiasis: an autopsy study of 355 patients.","volume":"77","author":"van Burik","year":"1998","journal-title":"Medicine"},{"key":"key-10.3201\/eid2111.150404-201510190655-R9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/clinids\/20.1.115","article-title":"Importance of Candida species other than C. albicans as pathogens in oncology patients.","volume":"20","author":"Wingard","year":"1995","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2111.150404-201510190655-R10","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1080\/13693780801968571","article-title":"Candida lusitaniae fungemia in cancer patients: risk factors for amphotericin B failure and outcome.","volume":"46","author":"Atkinson","year":"2008","journal-title":"Med Mycol"},{"key":"key-10.3201\/eid2111.150404-201510190655-R11","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1086\/497079","article-title":"Candida kefyr as an emerging pathogen causing nosocomial bloodstream infections in neutropenic leukemia patients.","volume":"41","author":"Reuter","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2111.150404-201510190655-R12","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1128\/JCM.00131-14","article-title":"Epidemiology of Candida kefyr in patients with hematologic malignancies.","volume":"52","author":"Dufresne","year":"2014","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid2111.150404-201510190655-R13","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1128\/JCM.00356-06","article-title":"Candida guilliermondii fungemia in patients with hematologic malignancies.","volume":"44","author":"Girmenia","year":"2006","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid2111.150404-201510190655-R14","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1086\/501768","article-title":"Nosocomial Candida guilliermondii fungemia in cancer patients.","volume":"21","author":"Mardani","year":"2000","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key-10.3201\/eid2111.150404-201510190655-R15","doi-asserted-by":"crossref","unstructured":"Johnson EM. Rare and emergingCandidaspecies. Current Fungal Infection Reports. 2009;3:152\u20139.","DOI":"10.1007\/s12281-009-0020-z"},{"key":"key-10.3201\/eid2111.150404-201510190655-R16","unstructured":"Clinical Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts, 4th ed. M27\u2013S4. Wayne (PA): The Institute. 2012."},{"key":"key-10.3201\/eid2111.150404-201510190655-R17","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1128\/JCM.00937-12","article-title":"Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012.","volume":"50","author":"Pfaller","year":"2012","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid2111.150404-201510190655-R18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/01.md.0000091182.93122.8e","article-title":"Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.","volume":"82","author":"Antoniadou","year":"2003","journal-title":"Medicine"},{"key":"key-10.3201\/eid2111.150404-201510190655-R19","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America.","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2111.150404-201510190655-R20","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1086\/382874","article-title":"Management of central venous catheters in patients with cancer and candidemia.","volume":"38","author":"Raad","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2111.150404-201510190655-R21","doi-asserted-by":"publisher","first-page":"e954","DOI":"10.1016\/j.ijid.2010.04.006","article-title":"Relative frequency of albicans and the various non-albicans Candida spp. among candidemia isolates from inpatients in various parts of the world: a systematic review.","volume":"14","author":"Falagas","year":"2010","journal-title":"Int J Infect Dis"},{"key":"key-10.3201\/eid2111.150404-201510190655-R22","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.diagmicrobio.2012.10.003","article-title":"Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance\u00ae) registry, 2004\u20132008.","volume":"74","author":"Pfaller","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key-10.3201\/eid2111.150404-201510190655-R23","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.3201\/eid2011.140685","article-title":"Drug-resistant Candida glabrata infection in cancer patients.","volume":"20","author":"Farmakiotis","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2111.150404-201510190655-R24","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/QCO.0000000000000111","article-title":"Echinocandin resistance: an emerging clinical problem?","volume":"27","author":"Arendrup","year":"2014","journal-title":"Curr Opin Infect Dis"},{"key":"key-10.3201\/eid2111.150404-201510190655-R25","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1093\/jac\/dkv087","article-title":"The ever-evolving landscape of candidaemia in patients with acute leukaemia: non-susceptibility to caspofungin and multidrug resistance are associated with increased mortality.","volume":"70","author":"Wang","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid2111.150404-201510190655-R26","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/j.1469-0691.2009.02821.x","article-title":"Candidemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management.","volume":"15","author":"Chen","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"key-10.3201\/eid2111.150404-201510190655-R27","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3109\/13693780903410386","article-title":"Multicenter surveillance of species distribution and antifungal susceptibilities of Candida bloodstream isolates in South Korea.","volume":"48","author":"Jung","year":"2010","journal-title":"Med Mycol"},{"key":"key-10.3201\/eid2111.150404-201510190655-R28","doi-asserted-by":"publisher","first-page":"e99103","DOI":"10.1371\/journal.pone.0099103","article-title":"Epidemiology and prognostic factors of candidemia in cancer patients.","volume":"9","author":"Tang","year":"2014","journal-title":"PLoS ONE"},{"key":"key-10.3201\/eid2111.150404-201510190655-R29","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1080\/003655401750174020","article-title":"Prospective study of fungaemia in a single cancer institution over a 10-y period: aetiology, risk factors, consumption of antifungals and outcome in 140 patients.","volume":"33","author":"Kovacicov\u00e1","year":"2001","journal-title":"Scand J Infect Dis"},{"key":"key-10.3201\/eid2111.150404-201510190655-R30","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.ijantimicag.2012.05.024","article-title":"Association between incidence of candidaemia and consumption of antifungal agents at a medical centre in Taiwan.","volume":"40","author":"Lai","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.3201\/eid2111.150404-201510190655-R31","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1086\/502104","article-title":"Breakthrough candidemia in patients with cancer differs from de novo candidemia in host factors and Candida species but not intensity.","volume":"23","author":"Kontoyiannis","year":"2002","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key-10.3201\/eid2111.150404-201510190655-R32","doi-asserted-by":"publisher","first-page":"O50","DOI":"10.1111\/1469-0691.12312","article-title":"A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies.","volume":"20","author":"Gamaletsou","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"key-10.3201\/eid2111.150404-201510190655-R33","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1128\/JCM.00865-06","article-title":"Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program.","volume":"44","author":"Pfaller","year":"2006","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid2111.150404-201510190655-R34","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/j.1439-0507.2010.01960.x","article-title":"What do we know about Candida guilliermondii? A voyage throughout past and current literature about this emerging yeast.","volume":"54","author":"Savini","year":"2011","journal-title":"Mycoses"},{"key":"key-10.3201\/eid2111.150404-201510190655-R35","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1007\/s10096-014-2096-9","article-title":"Emergence of echinocandin-resistant Candida spp. in a hospital setting: a consequence of 10 years of increasing use of antifungal therapy?","volume":"33","author":"Fekkar","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key-10.3201\/eid2111.150404-201510190655-R36","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.1128\/AAC.01519-13","article-title":"Interlaboratory variability of caspofungin MICs for Candida spp. using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?","volume":"57","author":"Espinel-Ingroff","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2111.150404-201510190655-R37","doi-asserted-by":"publisher","first-page":"6361","DOI":"10.1128\/AAC.01451-13","article-title":"Anidulafungin and micafungin MIC breakpoints are superior to that of caspofungin for identifying FKS mutant Candida glabrata strains and echinocandin resistance.","volume":"57","author":"Shields","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2111.150404-201510190655-R38","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1086\/524071","article-title":"Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact.","volume":"46","author":"Kanafani","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2111.150404-201510190655-R39","doi-asserted-by":"publisher","first-page":"5421","DOI":"10.1128\/AAC.00096-14","article-title":"Target enzyme mutations confer differential echinocandin susceptibilities in Candida kefyr.","volume":"58","author":"Staab","year":"2014","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/21\/11\/15-0404_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T23:19:01Z","timestamp":1732922341000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/21\/11\/15-0404_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,10]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2111.150404","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}